• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

Addressing the Challenges of Bile Acid Diarrhea Diagnosis

Addressing the Challenges of Bile Acid Diarrhea Diagnosis

by Michael Schubert, PhD | Jul 31, 2023 | Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

A new five-metabolite blood test designed by algorithm could simplify and speed up this challenging diagnosis.

This content is for Paid Members only.
Login Register
Can Ophthalmic Biomarkers Offer Insights into Brain Pathologies?

Can Ophthalmic Biomarkers Offer Insights into Brain Pathologies?

by Michael Schubert, PhD | Jul 31, 2023 | Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

Protein levels in the vitreous humor may have the potential to support the diagnosis and staging of neurodegenerative diseases.

This content is for Paid Members only.
Login Register
New Blood-Based PTSD Biomarkers Revealed

New Blood-Based PTSD Biomarkers Revealed

by Swathi Kodaikal, MSc | May 31, 2023 | Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

A simple blood test may help screen, identify, intervene, treat, monitor, and eventually, prevent PTSD.

This content is for Paid Members only.
Login Register
New Device Predicts the Efficacy of Hypnosis Treatment for Pain

New Device Predicts the Efficacy of Hypnosis Treatment for Pain

by Zahraa Chorghay, PhD | Apr 20, 2023 | Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

The inexpensive POC device is a biosensor that performs COMT genotyping as a biomarker for hypnotizability.

This content is for Paid Members only.
Login Register
Simplifying Antidepressant Quantification in Clinical Labs

Simplifying Antidepressant Quantification in Clinical Labs

by Morgana Moretti, PhD | Mar 23, 2023 | Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

A recent study provides insights on how to use automation and only 20 μL of a serum sample to quantify blood levels of antidepressants.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com